NYSE - Delayed Quote USD

AptarGroup, Inc. (ATR)

140.01 +0.27 (+0.19%)
At close: April 24 at 4:00 PM EDT
137.76 -2.25 (-1.61%)
After hours: April 24 at 6:51 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
3,487,450.00
3,487,450.00
3,322,249.00
3,227,221.00
2,929,340.00
Cost of Revenue
2,224,051.00
2,224,051.00
2,158,411.00
2,070,538.00
1,842,821.00
Gross Profit
1,263,399.00
1,263,399.00
1,163,838.00
1,156,683.00
1,086,519.00
Operating Expense
814,376.00
814,376.00
777,968.00
786,095.00
720,529.00
Operating Income
449,023.00
449,023.00
385,870.00
370,588.00
365,990.00
Net Non Operating Interest Income Expense
-36,045.00
-36,045.00
-38,127.00
-26,616.00
-32,286.00
Other Income Expense
-38,153.00
-38,153.00
-13,039.00
-22,317.00
-32,549.00
Pretax Income
374,825.00
374,825.00
334,704.00
321,655.00
301,155.00
Tax Provision
90,649.00
90,649.00
95,149.00
78,017.00
87,065.00
Net Income Common Stockholders
284,487.00
284,487.00
239,288.00
244,097.00
214,040.00
Diluted NI Available to Com Stockholders
284,487.00
284,487.00
239,288.00
244,097.00
214,040.00
Basic EPS
4.30
4.34
3.66
3.72
3.32
Diluted EPS
4.21
4.25
3.59
3.61
3.21
Basic Average Shares
65,480.00
65,616.00
65,402.00
65,663.00
64,418.00
Diluted Average Shares
66,749.00
66,905.00
66,719.00
67,682.00
67,682.00
Total Operating Income as Reported
404,019.00
404,019.00
379,273.00
347,348.00
339,498.00
Total Expenses
3,038,427.00
3,038,427.00
2,936,379.00
2,856,633.00
2,563,350.00
Net Income from Continuing & Discontinued Operation
284,487.00
284,487.00
239,288.00
244,097.00
214,040.00
Normalized Income
317,528.98
317,528.98
245,522.21
258,124.97
230,697.31
Interest Income
4,373.00
4,373.00
2,700.00
3,668.00
958.00
Interest Expense
40,418.00
40,418.00
40,827.00
30,284.00
33,244.00
Net Interest Income
-36,045.00
-36,045.00
-38,127.00
-26,616.00
-32,286.00
EBIT
415,243.00
415,243.00
375,531.00
351,939.00
334,399.00
EBITDA
663,836.00
663,836.00
609,237.00
586,792.00
554,699.00
Reconciled Cost of Revenue
2,224,051.00
2,224,051.00
2,158,411.00
2,070,538.00
1,842,821.00
Reconciled Depreciation
248,593.00
248,593.00
233,706.00
234,853.00
220,300.00
Net Income from Continuing Operation Net Minority Interest
284,487.00
284,487.00
239,288.00
244,097.00
214,040.00
Total Unusual Items Excluding Goodwill
-43,591.00
-43,591.00
-8,707.00
-18,531.00
-23,428.00
Total Unusual Items
-43,591.00
-43,591.00
-8,707.00
-18,531.00
-23,428.00
Normalized EBITDA
707,427.00
707,427.00
617,944.00
605,323.00
578,127.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-10,549.02
-10,549.02
-2,472.79
-4,503.03
-6,770.69
12/31/2020 - 4/23/1993

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

WST West Pharmaceutical Services, Inc.
385.73
-1.15%
 
UTMD Utah Medical Products, Inc.
67.16
-0.59%
 
ICUI ICU Medical, Inc.
96.72
-1.06%
 
ATRI Atrion Corporation
424.19
+4.66%
 
TFX Teleflex Incorporated
211.17
+0.03%
 
XRAY DENTSPLY SIRONA Inc.
30.92
+0.19%
 
AZTA Azenta, Inc.
52.09
-0.86%
 
EMBC Embecta Corp.
10.89
+0.09%
 
OSUR OraSure Technologies, Inc.
5.50
-0.54%
 
HAE Haemonetics Corporation
86.22
+1.35%